Company Email Format Management

Guard Therapeutics

Biotechnology Research Stockholm, Stockholms Län, Se 15 employees FIRST

Employees: 15
Contacts: 2
Emails: 2

guardtherapeutics.com LinkedIn

Guard Therapeutics Overview

Headquarters: Stockholm, Stockholms Län, Se
Phone Number: Available in AeroLeads
Website: guardtherapeutics.com
Industry: Biotechnology Research
Employees: 15
Stock Symbol: FIRST
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Guard Therapeutics

Guard Therapeutics is developing innovative therapies focusing on kidney diseases. The company's lead clinical asset, RMC-035, is in phase 2b development for the prevention and treatment of kidney injuries in patients undergoing open heart surgery. The company also has preclinical candidate drugs intended for the treatment of chronic kidney disease, targeting specific disease segments such as FSGS, IgAN, Alport Syndrome and DKD. Listed on Nasdaq First North Growth Market.

Guard Therapeutics Contact Details

People in AeroLeads: 2
With contact data: 2
Email contacts: 2; 100.0% coverage

Guard Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Khatereh Ahmadi	Head of Search and Evaluation Team	London, England, United Kingdom	Email
Camilla Svanström	Qc Manager, Cmc På Guard Therapeutics	Greater Malmö Metropolitan Area, Sweden	Email